IO Biotech, Inc.
IOBTDelisted Jun 8, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001865494
IO Biotech, Inc. was delisted on Jun 8, 2026; its insiders filed their last Form 4 on Jun 6, 2025; 12 institutions reported holding it in 13F filings for Q1 2026, worth $199.0K in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding IO Biotech, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 17 | 15 | −2 |
| Shares | 13.9M | 12.2M | −1.67M (−12.0%) |
| Value | $26.1M | $24.0M | −$2.13M (−8.2%) |
New holders (3)
Institutions that held IO Biotech, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Aureus Asset Management, LLC | 43,744 | $85.5K | 0.01% |
| Summit Trail Advisors, LLC | 43,744 | $85.5K | 0.00% |
| Two Sigma Securities, LLC | 13,020 | $25.5K | 0.00% |
Sold out (5)
Institutions that held IO Biotech, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Point72 Asset Management, L.P. | 1,400,000 | $2.63M |
| Capital World Investors | 418,499 | $782.6K |
| Newtyn Management, LLC | 49,346 | $92.3K |
| Millennium Management LLC | 19,917 | $37.0K |
| Cannell Capital LLC | 12,594 | $23.6K |